Gundersen Lutheran Medical Foundation Hematology and Medical Oncology

Topics

• Cancer Immunotherapy and Biomarkers 19
• Lung Cancer Treatments and Mutations 18
• Lymphoma Diagnosis and Treatment 13
• Multiple Myeloma Research and Treatments 9
• CAR-T cell therapy research 6
• Lung Cancer Research Studies 6
• Colorectal Cancer Screening and Detection 5
• Lung Cancer Diagnosis and Treatment 5
• Cancer Genomics and Diagnostics 4
• Colorectal Cancer Treatments and Studies 4
• Immune Cell Function and Interaction 4
• Venous Thromboembolism Diagnosis and Management 4

Most cited

1. Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.

   The Lancet. Oncology · 2024 · 173 citations · Dipesh Uprety

2. Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 195 citations · Shivani Kapur

3. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2021 · 260 citations · Lori Rosenstein

4. Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study.

   Blood cancer journal · 2024 · 95 citations · Vineel Bhatlapenumarthi

5. MET alterations in NSCLC-Current Perspectives and Future Challenges.

   Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2023 · 121 citations · Dipesh Uprety

6. Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma.